Clinical Trial Update: HIV Prevention Among Substance Abusing SMI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating HIV prevention in individuals with serious mental illness and substance use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mental Disorders
• Substance Use Disorder

Snippet

Sponsor: University of Pennsylvania | Conditions: Mentally Ill Persons, Substance Abuse | Phase 3 | Status: COMPLETED